Tirzepatide 10mg is a novel GLP-1/GIP dual receptor agonist peptide with demonstrated efficacy in metabolic research applications. This pharmaceutical grade compound is supplied as a white lyophilized powder with purity exceeding 99% by HPLC analysis.
The tirzepatide 10mg formulation represents a significant advancement in peptide therapeutics research, combining the glucose-dependent insulinotropic effects of both GLP-1 and GIP receptor agonism. Our production facility maintains strict quality control standards throughout the synthesis and purification process.
For research purposes only, this product is not intended for human consumption. Proper handling procedures should be followed, including the use of personal protective equipment when working with the material.
Storage recommendations for tirzepatide 10mg include maintaining the product at -20°C for long-term stability. The peptide should be protected from light and moisture to preserve its chemical integrity.
Our manufacturing capabilities allow for custom synthesis of tirzepatide 10mg in various quantities to meet specific research requirements. Each batch is accompanied by comprehensive analytical documentation including HPLC chromatograms and mass spectrometry verification.
The tirzepatide 10mg product is available in sterile vials suitable for research applications. Special packaging options can be arranged to meet specific transportation or storage needs.